Placental dysfunction and stillbirth in gestational diabetes mellitus

British Journal of Diabetes and Vascular Disease

Volumn 9, Issue 1, 2009, Pages 38-40

  Campbell, Ian W ^a   Duncan, Catriona ^a   Urquhart, Rennie ^a   Evans, Margaret ^a  

^a VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CASE REPORT; FEMALE; FETUS MORTALITY; FIBROSIS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HISTOPATHOLOGY; HUMAN; PLACENTA DISORDER; PLACENTA FUNCTION; PREGNANCY DIABETES MELLITUS; STILLBIRTH;

EID: 73449092516     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/1474651408101348     Document Type: Article

References (5)

1. Mondestin MAJ, Ananth CV, Smulian JC et al. Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy. Am J Obstet Gynaecol 2002 ; 187: 922-926.
2. Daskalakis G., Marinopoulos S., Krielesi V. et al. Placental pathology in women with gestational diabetes. Acta Obstet Gynecol 2008 ; 87: 403-407.
3. Becker T., Meier C., Vermeulen MJ et al. Pre-pregnancy diabetes and risk of placental vascular disease. Diabetes Care 2007 ; 30: 2496-2498.
4. Rowan JA, Hague WM, Gao W. et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008 ; 358: 2003-2015.
5. Wiernsperger NF Review: 50 years later: is metformin a vascular drug with anti-diabetic properties. Br J Diabetes Vasc Dis 2007 ; 7: 204-210.